Hugh Rickards

ORCID: 0000-0002-8678-5827
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Neurodegenerative Diseases
  • Obsessive-Compulsive Spectrum Disorders
  • Neurological disorders and treatments
  • Autism Spectrum Disorder Research
  • Parkinson's Disease Mechanisms and Treatments
  • Mitochondrial Function and Pathology
  • Eating Disorders and Behaviors
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Psychosomatic Disorders and Their Treatments
  • Epilepsy research and treatment
  • Neurology and Historical Studies
  • Mental Health and Psychiatry
  • Botulinum Toxin and Related Neurological Disorders
  • Schizophrenia research and treatment
  • Advanced Neuroimaging Techniques and Applications
  • Neuroscience and Neuropharmacology Research
  • Pharmacological Effects and Toxicity Studies
  • Body Image and Dysmorphia Studies
  • Attention Deficit Hyperactivity Disorder
  • Health Systems, Economic Evaluations, Quality of Life
  • EEG and Brain-Computer Interfaces
  • Mental Health Treatment and Access
  • Cannabis and Cannabinoid Research
  • Mental Health Research Topics
  • Psychiatric care and mental health services

University of Birmingham
2015-2024

Huntington's Disease Association
2016-2024

Birmingham and Solihull Mental Health NHS Foundation Trust
2012-2023

Centre for Mental Health
2012-2022

NIHR Surgical Reconstruction and Microbiology Research Centre
2019

Mental Health Foundation
2009-2018

University of Leicester
1996-2016

Leicestershire Partnership NHS Trust
2016

Cardiff University
2016

King's College London
2014

Huntington's disease is an autosomal-dominant neurodegenerative caused by CAG trinucleotide repeat expansion in HTT, resulting a mutant huntingtin protein. IONIS-HTTRx (hereafter, HTTRx) antisense oligonucleotide designed to inhibit HTT messenger RNA and thereby reduce concentrations of huntingtin. We conducted randomized, double-blind, multiple-ascending-dose, phase 1-2a trial involving adults with early disease. Patients were randomly assigned 3:1 ratio receive HTTRx or placebo as bolus...

10.1056/nejmoa1900907 article EN New England Journal of Medicine 2019-05-07

Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is significant limiting factor in maintenance. Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects cognitive function therefore compromise patient wellbeing. On other hand, some agents may serve enhance function. In this review paper, we highlight range cognition linked variety newer older AEDs, encompassing key alterations both...

10.1177/1756285611417920 article EN Therapeutic Advances in Neurological Disorders 2011-09-13

The majority of Huntington's disease (HD) mutation carriers experience some psychopathology during their lifetime, varying from irritability to psychosis, but prevalences particular symptoms vary widely due diverse study populations in different stages HD and the use assessment methods.The population consisted 1993 15 European countries, all participating observational REGISTRY study. behavioural section Unified Rating Scale was used examine prevalence correlates five neuropsychiatric...

10.1136/jnnp-2013-307343 article EN Journal of Neurology Neurosurgery & Psychiatry 2014-05-14

<b>Background:</b> Eighteen patients with severe and refractory Tourette syndrome (TS) underwent bilateral thalamic deep brain stimulation (DBS). <b>Objective:</b> To assess the long-term outcome on tics, behavioral symptoms, cognitive functions in largest case series of DBS for TS to date. <b>Methods:</b> In this prospective cohort study, 15 original 18 were evaluated before after surgery according a standardized protocol that included both neuropsychiatric neuropsychological assessments....

10.1212/wnl.0b013e3181bd809b article EN Neurology 2009-10-26

Tourette syndrome (TS) is a chronic neurodevelopmental disorder characterized by tics: repetitive, involuntary movements and vocalizations. These symptoms can have significant impact on patients’ daily functioning across many domains. Tics tend to be most severe in child adolescent sufferers, so their presence has the potential period of life that both critical for learning often associated with experience greater social tension self-consciousness than adulthood. Furthermore, control over...

10.1177/1756285610390261 article EN Therapeutic Advances in Neurological Disorders 2010-12-21

Abstract Pilot study of nabilone in Huntington's disease (HD). Double‐blind, placebo‐controlled, cross‐over versus placebo. Primary outcome, Unified Disease Rating Scale (UHDRS) total motor score. Secondary measures: UHDRS subsections for chorea, cognition and behavior, neuropsychiatric inventory (NPI). 44 randomized patients received either (1 or 2 mg) followed by placebo (n = 22), 22). Recruiting was straightforward. Nabilone safe well tolerated, no psychotic episodes. Assessment dose...

10.1002/mds.22809 article EN Movement Disorders 2009-10-20

Mental and neurological conditions are classified in different chapters of diagnostic manuals. <b>P D White</b>, <b>H Rickards</b>, <b>A Z J Zeman</b> argue that this distinction is inconsistent with current scientific understanding the should be grouped together as disorders nervous system

10.1136/bmj.e3454 article EN BMJ 2012-05-24

Tourette syndrome (TS) among young people is associated with psychosocial difficulties and parents play an important role in the management of condition. Clinical guidelines have been developed for treatment TS tics, but little known about how their perceive options or desired outcomes treatment. The aim this study to explore perceptions treatments tics parents. In-depth interviews 42 a mixed-methods, online survey 295 TS. Participant recruitment was conducted through Tourettes Action (TA):...

10.1186/s12888-015-0430-0 article EN cc-by BMC Psychiatry 2015-03-10
Ralf Reilmann Andrew McGarry Igor D. Grachev Juha‐Matti Savola Beth Borowsky and 95 more Eli Eyal Nicholas J. Gross Douglas R. Langbehn Robin Schubert Anna Teige Wickenberg Spyros Papapetropoulos Michael R. Hayden Ferdinando Squitieri Karl Kieburtz G. Bernhard Landwehrmeyer Pinky Agarwal Karen E. Anderson N. Ahmad Aziz J.P. Azulay Anne‐Catherine Bachoud‐Lévi Roger A. Barker Agnieszka Bebak Markus Beuth Kevin Biglan Stéphanie Blin Stefan Bohlen Raphael M. Bonelli Sue Caldwell Fabienne Calvas Jonielyn Carlos Simona Castagliuolo Terrence Chong Phyllis Chua Allison Coleman Jody Corey‐Bloom Rebecca Cousins David Craufurd Jill Davison E Decorte Giuseppe De Michele Laura Dornhege Andrew Feigin Stephanie Gallehawk Pascale Gauteul Carey Gonzales Jane Griffith А.В. Густов Mark Guttman Beatrix Heim Hope Heller Lena E. Hjermind С. Н. Иллариошкин Larry Ivanko Jessica Jaynes Mollie W. Jenckes Barbara Kaminski Anne Kampstra Agnieszka Konkel S V Kopishinskaya Pierre Krystkowiak Suresh K Komati Alexander Kwako Stefan Lakoning Guzal Latipova Blair R. Leavitt Clement T. Loy Cheryl MacFarlane Louise Madsen Karen Marder Sarah L. Mason Neila Mendis Tilak Mendis Andrea H. Németh Louise Nevitt Virginia Norris Christine J. O’Neill Audrey Olivier Michael Orth Ashley Owens Peter K. Panegyres Susan Perlman J. Samuel Preston Josef Priller Alicja Puch Oliver Quarrell Domenica Ragosta Amandine Rialland Hugh Rickards Anna Maria Romoli Christopher A. Ross Anne Rosser Monika Rudzińska Cinzina V Russo Carsten Saft Victoria Segro Klaus Seppi Barbara Shannon David Shprecher C. Simonin Zara Skitt

10.1016/s1474-4422(18)30391-0 article EN The Lancet Neurology 2018-12-15

Broome, M. R., & Bortolotti, L. (Eds.). (2009). Psychiatry as Cognitive Neuroscience: Philosophical Perspectives. Oxford, UK: Oxford University Press. Pp. 304. ISBN-13 9780199238033. $65.00 Prior t...

10.1080/13546805.2010.484297 article EN Cognitive Neuropsychiatry 2010-06-09

Schachter, S. C., & LaFrance, W. Jr. (Eds.). (2010). Gates and Rowan's non-epileptic seizures (3rd ed.). Cambridge, UK: Cambridge University Press. Pp. 370. ISBN 978 0 521 51763 8. $130.00 Rece...

10.1080/13546805.2011.564492 article EN Cognitive Neuropsychiatry 2011-04-01

Previous studies indicate increased prevalences of suicidal ideation, suicide attempts, and completed in Huntington's disease (HD) compared with the general population. This study investigates correlates predictors ideation HD.The cohort consisted 2106 HD mutation carriers, all participating REGISTRY European Disease Network. Of 1937 participants without at baseline, 945 had one or more follow-up measurements. Participants were assessed for by behavioural subscale Unified Rating Scale...

10.1016/j.jad.2013.06.001 article EN publisher-specific-oa Journal of Affective Disorders 2013-07-20

It is estimated that one in five patients referred to specialist epilepsy clinics for refractory seizures have psychogenic nonepileptic (PNES). Despite the high prevalence, little known about prognosis of with PNES. In this paper we set out systematically assess published original studies on and outcome predictors Our literature search across databases Medline, PsycINFO, EMBASE generated 18 meeting criteria. Prognosis was found be poor adults, but good children. Predictors included presence...

10.1155/2011/274736 article EN Epilepsy Research and Treatment 2011-02-09

This study aimed to evaluate the feasibility and benefit of a structured exercise intervention in people with Huntington's Disease (HD).This was conducted at 6 sites, participants were randomized into either or control (usual care) groups, assessed baseline, 13 26 weeks. The 12 week, three times per week progressive program, including aerobic (stationary cycling) upper lower body strengthening tapered 1:1 support for 20 36 sessions.314 adults eligibility: 248 did not meet inclusion criteria,...

10.1016/j.parkreldis.2016.06.023 article EN cc-by-nc-nd Parkinsonism & Related Disorders 2016-07-03
Coming Soon ...